scholarly article | Q13442814 |
P2093 | author name string | Grant D Trobridge | |
Casey P Collins | |||
Jonah D Hocum | |||
Victor M Bii | |||
P2860 | cites work | Cloning of DPK, a novel dendritic cell-derived protein kinase activating the ERK1/ERK2 and JNK/SAPK pathways | Q22254727 |
Mutational heterogeneity in cancer and the search for new cancer-associated genes | Q24606956 | ||
Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression | Q24657250 | ||
BLAT—The BLAST-Like Alignment Tool | Q24682492 | ||
Identifying Cancer Driver Genes Using Replication-Incompetent Retroviral Vectors | Q28077919 | ||
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease | Q28143064 | ||
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1 | Q28210584 | ||
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy | Q28215190 | ||
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data | Q28266682 | ||
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal | Q28288215 | ||
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1 | Q28290118 | ||
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
Uncovering and dissecting the genotoxicity of self-inactivating lentiviral vectors in vivo | Q28383769 | ||
The mutational landscape of lethal castration-resistant prostate cancer | Q29614634 | ||
The development of androgen-independent prostate cancer | Q29615650 | ||
Oncomine 3.0: genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles | Q29617464 | ||
Transcription start regions in the human genome are favored targets for MLV integration | Q29618456 | ||
HIV-1 integration in the human genome favors active genes and local hotspots | Q29618457 | ||
NOTCH1 signaling promotes chemoresistance via regulating ABCC1 expression in prostate cancer stem cells. | Q51516890 | ||
Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. | Q51596197 | ||
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression | Q57693549 | ||
Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease | Q57908314 | ||
Gene expression correlates of clinical prostate cancer behavior | Q60156349 | ||
Multidrug resistance in small cell lung cancer: expression of P-glycoprotein, multidrug resistance protein 1 and lung resistance protein in chemo-naive patients and in relapsed disease | Q80171272 | ||
New views into the prostate cancer genome | Q84538547 | ||
Integrative genomic profiling of human prostate cancer | Q29619905 | ||
SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis | Q30670039 | ||
Identification of novel androgen-responsive genes by sequencing of LongSAGE libraries | Q30875945 | ||
Integrative molecular concept modeling of prostate cancer progression. | Q33266777 | ||
Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors | Q33713156 | ||
TAO (thousand-and-one amino acid) protein kinases mediate signaling from carbachol to p38 mitogen-activated protein kinase and ternary complex factors. | Q34187021 | ||
Foamy virus vector integration sites in normal human cells | Q34334976 | ||
PEAR: a fast and accurate Illumina Paired-End reAd mergeR. | Q34379012 | ||
The Molecular Taxonomy of Primary Prostate Cancer | Q34674332 | ||
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance | Q35083279 | ||
Gene expression profiling identifies clinically relevant subtypes of prostate cancer | Q35554359 | ||
Lentiviral vector-based insertional mutagenesis identifies genes involved in the resistance to targeted anticancer therapies | Q35600324 | ||
VISA--Vector Integration Site Analysis server: a web-based server to rapidly identify retroviral integration sites from next-generation sequencing | Q35684865 | ||
Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations. | Q35913748 | ||
Androgen deprivation therapy for prostate cancer | Q36193125 | ||
Retroviral insertional mutagenesis: past, present and future | Q36318150 | ||
A novel gammaretroviral shuttle vector insertional mutagenesis screen identifies SHARPIN as a breast cancer metastasis gene and prognostic biomarker | Q36545417 | ||
Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer | Q36660711 | ||
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy | Q37143395 | ||
A conditional transposon-based insertional mutagenesis screen for genes associated with mouse hepatocellular carcinoma. | Q37266967 | ||
Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer | Q38350670 | ||
Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression | Q38352372 | ||
Common cancer biomarkers | Q38438443 | ||
Lentiviral vector-mediated insertional mutagenesis screen identifies genes that influence androgen independent prostate cancer progression and predict clinical outcome | Q38824007 | ||
A novel approach to identify driver genes involved in androgen-independent prostate cancer | Q38989441 | ||
Influence of Etoposide on anti-apoptotic and multidrug resistance-associated protein genes in CD133 positive U251 glioblastoma stem-like cells | Q39715340 | ||
Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma | Q39807521 | ||
Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells | Q40291759 | ||
Gene expression analysis of prostate cancers | Q40664417 | ||
Molecular mechanisms of androgen-independent growth of human prostate cancer LNCaP-AI cells | Q40920978 | ||
High-malignancy orthotopic nude mouse model of human prostate cancer LNCaP. | Q40953238 | ||
PiggyBac as a novel vector in cancer gene therapy: current perspective | Q40993465 | ||
Use of a hormone-sensitive (LNCaP) and a hormone-resistant (LNCaP-r) cell line in prostate cancer research | Q41110185 | ||
Modified Genomic Sequencing PCR Using the MiSeq Platform to Identify Retroviral Integration Sites | Q41296473 | ||
Mutation of the androgen-receptor gene in metastatic androgen-independent prostate cancer | Q41344070 | ||
High-throughput genomic mapping of vector integration sites in gene therapy studies | Q42203739 | ||
Expression profiling reveals hepsin overexpression in prostate cancer. | Q43691850 | ||
Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer | Q43708520 | ||
Tumor immunobiological differences in prostate cancer between African-American and European-American men. | Q44513168 | ||
Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population | Q45864064 | ||
High-resolution insertion-site analysis by linear amplification-mediated PCR (LAM-PCR). | Q45873348 | ||
Genome-wide retroviral insertional tagging of genes involved in cancer in Cdkn2a-deficient mice | Q48286983 | ||
P433 | issue | 21 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 15451-15463 | |
P577 | publication date | 2018-02-15 | |
P1433 | published in | Oncotarget | Q1573155 |
P1476 | title | Replication-incompetent gammaretroviral and lentiviral vector-based insertional mutagenesis screens identify prostate cancer progression genes. | |
P478 | volume | 9 |
Search more.